Palo Alto, California —Connecting doctors and patients using technology is no easy task. There are an abundant amount of regulations that must be followed in order to meet HIPAA’s communication and data security standards. But a company in Palo Alto, California is looking to rethink how we transfer data at the app level.

Meet Medable, a HIPAA compliant platform for building mobile apps. Medable is looking to become an industry standard across consumer healthcare apps as well as integrate themselves into connected medical devices. It’s estimated that 80% of a health app’s development cost is from making it meet security guidelines. Medable aims to standardize and reduce this cost allowing developers to focus on their content instead of data security.


The platform provides an SDK (software development kit) and an API (application programming interface) to provide HIPAA compliant data transfers for app developers. It also uses the HL7 clinical data format so it can connect with many EHRs, protecting health information by encrypting the data on the device and in transit. Additionally, Medable will anonymize data for clinical data reporting and population health.

As healthcare technology continues to evolve, this platform aims to standardize the process of data security using the device that we already have… our smartphones.

Posted By: Mike Martins

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.